QuiVad

Home / Funds / Voleon Capital Management LP

Voleon Capital Management LP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Zealand Pharma A/SDenmark1.11%May 19, 2026
B&M European Value Retail S.A.Germany0.79%April 20, 2026
Oryzon Genomics, S.A.Spain0.63%July 3, 2026
Gubra A/SDenmark0.59%March 23, 2026
Lang & Schwarz AktiengesellschaftGermany0.59%February 2, 2022
Tubacex, S.A.Spain0.59%June 30, 2026
Medigene AGGermany0.55%December 4, 2017
Atos GroupFrance0.50%July 21, 2026

History of disclosures

6109 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
April 6, 2021Cell Impact AB (publ)Sweden1.10%still open
April 6, 2021Duro Felguera, S.A.Spain0.84%still open
April 6, 2021Immunovia AB (publ)Sweden0.70%still open
April 6, 2021Tecnicas Reunidas, S.A.Spain0.57%still open
April 6, 20214D Pharma PLCUnited Kingdom0.52%still open
April 6, 2021Maire SPAItaly0.49%still open
April 6, 2021Maire Tecnimont SPAItaly0.49%still open
April 6, 2021Digital Bros SPAItaly0.45%still open
April 1, 2021Eurotech SPAItaly1.55%still open
April 1, 2021Digital Bros SPAItaly0.58%still open
April 1, 20214D Pharma PLCUnited Kingdom0.44%still open
March 31, 2021Cell Impact AB (publ)Sweden1.06%still open
March 31, 2021Duro Felguera, S.A.Spain0.74%still open
March 31, 2021Digital Bros SPAItaly0.65%still open
March 31, 2021Tecnicas Reunidas, S.A.Spain0.60%still open
March 31, 2021Metabolic ExplorerFrance0.52%April 15, 2021
March 30, 2021Digital Bros SPAItaly0.71%still open
March 30, 2021Duro Felguera, S.A.Spain0.64%still open
March 30, 20214D Pharma PLCUnited Kingdom0.58%still open
March 30, 2021Oncopeptides ABSweden0.58%still open
March 30, 2021Maire SPAItaly0.50%still open
March 30, 2021Maire Tecnimont SPAItaly0.50%still open
March 29, 2021Eurotech SPAItaly1.66%still open
March 29, 2021Digital Bros SPAItaly0.81%still open
March 29, 2021Oncopeptides ABSweden0.66%still open
March 26, 20214D Pharma PLCUnited Kingdom0.69%still open
March 25, 2021BiophytisFrance1.09%June 18, 2021
March 25, 2021Cell Impact AB (publ)Sweden0.94%still open
March 25, 2021Immunovia AB (publ)Sweden0.60%still open
March 24, 2021BiophytisFrance1.10%June 18, 2021
March 24, 2021Nicox SAFrance0.70%May 19, 2021
March 24, 2021Tecnicas Reunidas, S.A.Spain0.50%still open
March 23, 2021Metro Bank PLCUnited Kingdom0.69%still open
March 23, 2021Duro Felguera, S.A.Spain0.52%still open
March 22, 2021NavyaFrance1.41%August 3, 2021
March 22, 20214D Pharma PLCUnited Kingdom0.75%still open
March 19, 2021Eurotech SPAItaly1.53%still open
March 19, 20214D Pharma PLCUnited Kingdom0.95%still open
March 19, 2021Digital Bros SPAItaly0.91%still open
March 18, 2021Eurotech SPAItaly1.44%still open
March 18, 20214D Pharma PLCUnited Kingdom0.84%still open
March 18, 2021Metro Bank PLCUnited Kingdom0.76%still open
March 18, 2021Oncopeptides ABSweden0.70%still open
March 17, 2021Digital Bros SPAItaly0.85%still open
March 17, 20214D Pharma PLCUnited Kingdom0.76%still open
March 17, 2021Nicox SAFrance0.60%May 19, 2021
March 17, 2021Strategic Partners A/SDenmark0.49%March 17, 2021
March 16, 2021NavyaFrance1.31%August 3, 2021
March 16, 2021Digital Bros SPAItaly0.76%still open
March 16, 2021AmoebaFrance0.47%March 18, 2021

The funds short on the same companies

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Voleon Capital Management LP, data as at July 21, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=63